SARS-CoV-2 Spike S1 蛋白
(SARS-CoV-2 Spike S1)
attaches the virion to the cell membrane by interacting with host receptor, initiating the infection (By similarity). Binding to human ACE2 receptor and internalization of the virus into the endosomes of the host cell induces conformational changes in the Spike glycoprotein (PubMed:32142651, PubMed:32075877, PubMed:32155444). Uses also human TMPRSS2 for priming in human lung cells which is an essential step for viral entry (PubMed:32142651). Proteolysis by cathepsin CTSL may unmask the fusion peptide of S2 and activate membranes fusion within endosomes.
Recommended next Filters:
您想试用我们的人工智能搜索吗？
104 results
宿主: SARS Coronavirus-2 (SARS-CoV-2)
宿主: HEK-293 Cells
Recombinant
The purity of the protein is greater than 95 % as determined by SDS-PAGE and Coomassie blue staining.
WB
1 image
宿主: SARS Coronavirus-2 (SARS-CoV-2)
宿主: 大肠杆菌（E. Coli）
Recombinant
> 90 %
WB, SDS, Imm, PC
1 image
宿主: SARS Coronavirus-2 (SARS-CoV-2)
宿主: HEK-293 Cells
> 95 %
1 image
1 reference
宿主: SARS Coronavirus-2 (SARS-CoV-2)
宿主: HEK-293 Cells
Recombinant
>90 % as determined by SDS-PAGE.
Active
宿主: SARS Coronavirus-2 (SARS-CoV-2), SARS CoV-2 Beta
宿主: HEK-293 Cells
Recombinant
>90 % as determined by SDS-PAGE.
Active
宿主: SARS Coronavirus-2 (SARS-CoV-2)
宿主: HEK-293 Cells
Recombinant
>90 % as determined by SDS-PAGE.
Active
宿主: SARS Coronavirus-2 (SARS-CoV-2), SARS CoV-2 Beta
宿主: HEK-293 Cells
Recombinant
>95 % as determined by SDS-PAGE.
Active
宿主: SARS Coronavirus-2 (SARS-CoV-2)
宿主: HEK-293 Cells
Recombinant
>95 % as determined by SDS-PAGE.
SDS, ELISA
宿主: SARS Coronavirus-2 (SARS-CoV-2)
宿主: HEK-293 Cells
Recombinant
>90 % as determined by SDS-PAGE.
SDS, ELISA
宿主: SARS Coronavirus-2 (SARS-CoV-2)
宿主: HEK-293 Cells
Recombinant
>95 % as determined by SDS-PAGE.
Active
宿主: SARS Coronavirus-2 (SARS-CoV-2)
宿主: HEK-293 Cells
Recombinant
>90 % as determined by SDS-PAGE.
Active
宿主: SARS Coronavirus-2 (SARS-CoV-2)
宿主: Tobacco (Nicotiana benthamiana)
Recombinant
≥ 85 %
宿主: SARS Coronavirus (SARS-CoV)
宿主: HEK-293 Cells
Recombinant
> 90 % by SDS-PAGE.
Active
宿主: SARS Coronavirus (SARS-CoV)
宿主: HEK-293 Cells
Recombinant
> 90 % by SDS-PAGE.
Active
宿主: SARS Coronavirus-2 (SARS-CoV-2)
宿主: HEK-293 Cells
Recombinant
> 85 % by SDS-PAGE.
Active
宿主: SARS Coronavirus-2 (SARS-CoV-2)
宿主: HEK-293 Cells
Recombinant
> 95 % by SDS-PAGE.
Active
宿主: SARS Coronavirus-2 (SARS-CoV-2)
宿主: HEK-293 Cells
Recombinant
>95 % (SDS-PAGE)
Active
宿主: SARS Coronavirus-2 (SARS-CoV-2)
宿主: HEK-293 Cells
Recombinant
>95 % (SDS-PAGE)
Active
宿主: SARS Coronavirus-2 (SARS-CoV-2)
宿主: CHO Cells
Recombinant
>95 % as determined by SDS-PAGE and HPLC
宿主: SARS Coronavirus-2 (SARS-CoV-2)
宿主: HEK-293 Cells
Recombinant
>95 % (SDS-PAGE)
Active
Latest Publications for our SARS-CoV-2 Spike S1 蛋白
: "Blood-brain barrier penetration of non-replicating SARS-CoV-2 and S1 variants of concern induce neuroinflammation which is accentuated in a mouse model of Alzheimer's disease." in: Brain, behavior, and immunity, Vol. 109, pp. 251-268, (2023) (PubMed).: "Point-of-care (POC) SARS-CoV-2 antigen detection using functionalized aerosol jet-printed organic electrochemical transistors (OECTs)." in: Nanoscale, Vol. 15, Issue 11, pp. 5476-5485, (2023) (PubMed).
: "Flow-Mediated Susceptibility and Molecular Response of Cerebral Endothelia to SARS-CoV-2 Infection." in: Stroke, Vol. 52, Issue 1, pp. 260-270, (2021) (PubMed).
: "Orthogonal immunoassays for IgG antibodies to SARS-CoV-2 antigens reveal that immune response lasts beyond 4 mo post illness onset." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 118, Issue 5, (2021) (PubMed).
: "SARS-CoV-2 specific antibody and neutralization assays reveal the wide range of the humoral immune response to virus." in: Communications biology, Vol. 4, Issue 1, pp. 129, (2021) (PubMed).
: "Protein Footprinting, Conformational Dynamics, and Core Interface-Adjacent Neutralization "Hotspots" in the SARS-CoV-2 Spike Protein Receptor Binding Domain/Human ACE2 Interaction." in: Journal of the American Society for Mass Spectrometry, (2021) (PubMed).
: "Antibody Affinity Governs the Inhibition of SARS-CoV-2 Spike/ACE2 Binding in Patient Serum." in: ACS infectious diseases, (2021) (PubMed).
: "Delayed production of neutralizing antibodies correlates with fatal COVID-19. ..." in: Nature medicine, (2021) (PubMed).
: "Divergent and self-reactive immune responses in the CNS of COVID-19 patients with neurological symptoms. ..." in: Cell reports. Medicine, pp. 100288, (2021) (PubMed).
: "A SARS-CoV-2 neutralizing antibody with extensive Spike binding coverage and modified for optimal therapeutic outcomes. ..." in: Nature communications, Vol. 12, Issue 1, pp. 2623, (2021) (PubMed).
Aliases for SARS-CoV-2 Spike S1 蛋白
Surface Glycoprotein (S) 蛋白E2 蛋白
您还需要查找其他产品吗？
- SARS-CoV-2 Spike 蛋白
- SARS-CoV-2 Nucleocapsid 蛋白
- SARS-CoV-2 NSP7 蛋白
- SARS-CoV-2 NSP5 (3CL-Pro) 蛋白
- SARS-CoV-2 NSP3 蛋白
- SARS-CoV Spike 蛋白
- SARS-Coronavirus Nucleocapsid Protein 蛋白
- SARS-Coronavirus Membrane Protein 蛋白
- SARNP 蛋白
- SARM1 蛋白
- SARDH 蛋白
- Sarcolemma Associated Protein 蛋白
- Sarcalumenin 蛋白
- SAR1B 蛋白
- SAR1A 蛋白
- SAPS2 蛋白
- SAPS1 蛋白
- SAP30BP 蛋白
- SAP30-Like 蛋白
- SAP30 蛋白
You are here:
